Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Pancreatic Neoplasms 5 Neoplastic Cells, Circulating 4 Neoplasm Metastasis 4 Biliary Tract Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm, Residual 3 Disease 3 Nevi and Melanomas 2 Neuroendocrine Tumors 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Sarcoma, Ewing 1

Interventions

palbociclib 6 Letrozole 6 Docetaxel 6 Anastrozole 6 exemestane 5 Trastuzumab 5 Fulvestrant 5 ribociclib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 pyrotinib 3 Doxorubicin 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Capecitabine 2 Botulinum Toxins, Type A 2 AZD9833 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05814224 2023-04-14

MAGNETIC1

Centro di Riferimento Oncologico - Aviano

Phase NA Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡